Aim Immunotech Inc (AIM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 04-2003 | 03-2003 | 01-2003 | 12-2002 | 10-2002 | |
| Sales | 8,744 | 66 | 6,683 | 78 | 7,001 |
| Cost of Goods | 5,831 | 118 | 4,109 | N/A | 4,569 |
| Gross Profit | 2,913 | -52 | 2,574 | 78 | 2,432 |
| Operating Expenses | 3,174 | 1,658 | 2,273 | 782 | 2,609 |
| Operating Income | 570 | -1,592 | 410 | -704 | 392 |
| Interest Expense | 53 | 17 | 49 | 0 | 34 |
| Other Income | 3 | -8 | 4 | 2,089 | 141 |
| Pre-tax Income | 520 | -1,617 | 365 | 1,385 | 499 |
| Income Tax | 17 | N/A | -42 | N/A | 16 |
| Net Income Continuous | 503 | -1,617 | 407 | 1,385 | 483 |
| Net Income | $503 | $-1,617 | $407 | $1,385 | $483 |
| EPS Basic Total Ops | 0.13 | -26.44 | 0.11 | -21.15 | 0.12 |
| EPS Basic Continuous Ops | 0.13 | -26.40 | 0.10 | 22.83 | 0.12 |
| EPS Diluted Total Ops | 0.13 | -26.44 | 0.11 | -21.15 | 0.12 |
| EPS Diluted Continuous Ops | 0.13 | -26.40 | 0.10 | 22.83 | 0.12 |
| EBITDA(a) | $852 | $-1,477 | $755 | $-557 | $593 |